BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin A, Zhang H, Meng H, Deng Z, Gu T, Luo P, Zhang J. TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer. Front Immunol 2021;12:667875. [PMID: 34603277 DOI: 10.3389/fimmu.2021.667875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang C, Liu J, Yang C, Ma J, Chen X, Liu D, Zhou Y, Zhou W, Lin Y, Yuan X. Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations. Biomolecules 2022;12:1636. [DOI: 10.3390/biom12111636] [Reference Citation Analysis]
2 Lin A, Fang J, Cheng Q, Liu Z, Luo P, Zhang J. B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis. J Inflamm Res 2022;15:5541-55. [PMID: 36176353 DOI: 10.2147/JIR.S379016] [Reference Citation Analysis]
3 Liu R, Liang W, Hua Q, Wu L, Wang X, Li Q, Zhong F, Li B, Qiu Z. Fatty Acid Metabolic Signaling Pathway Alternation Predict Prognosis of Immune Checkpoint Inhibitors in Glioblastoma. Front Immunol 2022;13:819515. [DOI: 10.3389/fimmu.2022.819515] [Reference Citation Analysis]